Migraine : Acute remote triage

• Migraine is a common and debilitating neurological disorder characterized by severe, recurrent headaches often accompanied by nausea, vomiting, photophobia, and phonophobia (Pasula et al., 2020; Ahmed et al., 2023).
• It ranks second globally in terms of disease burden, significantly contributing to years lived with disability (Davidsson et al., 2021).
• Lifetime prevalence is estimated at 11.7%, affecting millions annually (Davidsson et al., 2021).
• Many patients report unmet treatment needs, emphasizing the necessity for improved acute and preventive management strategies (Zhao et al., 2023).
• 
  

📌 First-Line Treatment for Acute Migraine

• NSAIDs (e.g., ibuprofen, naproxen) and triptans (e.g., sumatriptan, rizatriptan) are first-line pharmacological options (Tepper et al., 2021).
• Early administration of these medications improves effectiveness, reducing the duration and severity of attacks (Worthington et al., 2013).
• Challenges with acute treatments include ineffectiveness, poor tolerance, and risk of medication overuse headache (MOH) (Pasula et al., 2020; Martelletti et al., 2018).

🔍 Acute Headache Triage – Red Flag Checklist

🚨 Select any red flags that apply. If any are checked, urgent evaluation is required.